First Trust Advisors
TBIO

First Trust Advisors’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

First Trust Advisors’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-34,466
Closed -$949K – 2698
2021
Q2 		$949K Sell
34,466
-164,089
-83% -$3.22M ﹤0.01% 2078
2021
Q1 		$3.27M Buy
198,555
+115,278
+138% +$2.63M ﹤0.01% 1509
2020
Q4 		$1.53M Buy
+83,277
New +$1.49M ﹤0.01% 1717

First Trust Advisors's TBIO Position: Q3 2021 in Review

First Trust Advisors sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 34,466 shares — an estimated $949K sold.

First Trust Advisors first reported a position in TBIO in Q4 2020 and held it in 3 quarters. The position peaked at $3.27M in Q1 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • First Trust Advisors reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • First Trust Advisors sold 34,466 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $949K.
  • First Trust Advisors first reported a position in Translate Bio, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
  • First Trust Advisors's Translate Bio, Inc. Common Stock position peaked at $3.27M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on First Trust Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.